Research and product development
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | GLAUKOS CORPORATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$280,000 | |
| 2025 | GLAUKOS CORPORATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$60,000 | |
| 2025 | GLAUKOS CORPORATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2025 | GLAUKOS CORPORATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | |
| 2025 | GLAUKOS CORPORATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$45,000 | |
| 2024 | GLAUKOS CORPORATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$70,000 | |
| 2024 | GLAUKOS CORPORATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$70,000 | |
| 2024 | GLAUKOS CORPORATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$70,000 | |
| 2024 | GLAUKOS CORPORATION |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| GLAUKOS CORPORATION | 9 | $695,000 |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 7 |
| Taxation/Internal Revenue Code | 6 |
| Medical/Disease Research/Clinical Labs | 6 |